ASCO® 2023 Insights: "Phase III NATALEE Trial - Ribociclib + ET as Adjuvant Treatment in Patients With HR+/HER2- eBC"

By ecancer FEATURING Dennis Slamon
By ecancer FEATURING Dennis Slamon
950 views
June 14, 2023
Comments 0
Login to view comments. Click here to Login